Does subjective burden of early breast cancer and its treatment affect immune measures during adjuvant therapy?

Autor: Sabbioni, Marzio E E, Bernhard, Jürg, Siegrist, Hans-Peter, Schmitz, Shu-Fang Hsu, Gertsch, Monica Castiglione, Thürlimann, Beat, Bonnefoi, Hervé, Perey, Lucien, Herrmann, Richard, Goldhirsch, Aron, Hürny, Christoph, Swiss Group for Clinical Cancer Research, (SAKK)

Publikováno v: Sabbioni, Marzio E E; Bernhard, Jürg; Siegrist, Hans-Peter; Schmitz, Shu-Fang Hsu; Gertsch, Monica Castiglione; Thürlimann, Beat; Bonnefoi, Hervé; Perey, Lucien; Herrmann, Richard; Goldhirsch, Aron; Hürny, Christoph; Swiss Group for Clinical Cancer Research, (SAKK) (2004). Does subjective burden of early breast cancer and its treatment affect immune measures during adjuvant therapy? Breast cancer research and treatment, 87(1), pp. 75-86. Dordrecht: Springer 10.1023/B:BREA.0000041584.53863.a7

Psychosocial factors have been described as affecting cellular immune measures in healthy subjects. In patients with early breast cancer we explored bi-directional psycho-immune effects to determine whether subjective burden has an impact on immune m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e53eaab4f6cbf7ca33134b7d4a1ef1ca
https://boris.unibe.ch/37816/1/Sabbioni2004_Article_DoesSubjectiveBurdenOfEarlyBre.pdf